NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Mo

NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Moderate Buy" by Brokerages

NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Moderate Buy" by Brokerages

theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , United States , Aliciac Olivo , Piper Sandler , William Blair , Capital Partners , Neogenomics Company Profile , Financial Services Group Inc , Group Plc , Clinical Services , Goldman Sachs Group , Dell Group , Neogenomics Inc , Needham Company , Nasdaq , Pricet Rowe Associates Inc , Get Free Report , General Counsel Alicia , Services Group , General Group Plc , Get Free , Advanced Diagnostics , Neogenomics Daily ,